Protectant film for skin
Granted 19 Mar 2002 · 2 office actions
Assignee: Coloplast Corp
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Donald Lee Gerrish · Examiner: Thurman K. Page · AU 1615 · TC 1600
Life of the application
10 dated eventsAbstract
An improved skin-protecting film-forming composition uses the polymer cycloalkyl methacrylate copolymer. In general, a composition according to the present invention comprises: cycloalkyl methacrylate copolymer; an evaporative solvent comprising at least one solvent for the cycloalkyl methacrylate copolymer that can evaporate so that the copolymer is deposited on the skin; and a plasticizer to provide flexibility to the film deposited on the skin. The composition dries to produce a protective film for skin when applied to the skin of a user. A preferred composition according to the present invention comprises about 19 percent of cycloalkyl methacrylate copolymer, about 1 percent of acetyl tributyl citrate, about 30 percent of isooctane, and about 50 percent of hexamethyldisiloxane. Another composition according to the present invention comprises about 19 percent of cycloalkyl methacrylate copolymer, about 1 percent of acetyl tributyl citrate, about 19 percent of isooctane, about 11 percent of isododecane, and about 50 percent of hexamethyldisiloxane.
Description
4 parts›BACKGROUND OF THE INVENTION
This invention is directed to a composition that dries to produce a protective film for skin when applied to the skin of a user.
In many circumstances, it is desirable to apply a protectant film to the skin. Such film protectants are particularly desirable in circumstances in which a wound or opening is present for a long period of time and must be protected. Such protectants are particularly useful in connection with incontinence and ostomy appliances, such as are used after a colostomy. Such films should protect the skin against germs, feces, enzymatic drainage or wound drainage, as well as adhesive trauma. Additionally, such films should be flexible on the skin so that they will not crack or flake and should not interfere with adhesion of ostomy appliances, wound care dressing, tape, or attachable breast forms. Moreover, such films should leave a shiny appearance so that one can see that the film has been applied, and should not leave a residue or irritate the skin.
Although a number of films for such uses currently exist, there is a need for films with improved properties that meet the exacting demands of use, particularly in the case of ostomy apertures. There is therefore a need for skin-protecting film-forming polymers with improved properties.
›SUMMARY
A composition according to the present invention that dries to produce a protective film for skin when applied to the skin of a user comprises:
(1) cycloalkyl methacrylate copolymer;
(2) an evaporative solvent comprising at least one solvent for the cycloalkyl methacrylate copolymer that can evaporate so that the copolymer is deposited on the skin; and
(3) a plasticizer to provide flexibility to the film deposited on the skin.
A preferred cycloalkyl methacrylate copolymer is a bicycloalkyl methacrylate copolymer.
Typically, the solvent system comprises hexamethyldisiloxane and at least one saturated branched-chain hydrocarbon selected from the group consisting of isooctane, isodecane, and isododecane. Preferably, the saturated branched-chain hydrocarbon is isooctane. Alternatively, the saturated branched-chain hydrocarbon can be a mixture of isooctane and isododecane.
Typically, the plasticizer is selected from the group consisting of acetyl tributyl citrate, acetyl triethyl citrate, tributyl citrate, triethyl citrate, acetyl tripropyl citrate, tripropyl citrate, dibutyl sebacate, acetyl dibutyl sebacate, dipropyl sebacate, acetyl dipropyl sebacate, diethyl sebacate, and acetyl diethyl sebacate. Preferably, the plasticizer is acetyl tributyl citrate.
Preferably, the composition comprises from about 5 percent to about 25 percent of the cycloalkyl methacrylate copolymer, from about 73 percent to about 94.5 percent of the evaporative solvent, and from about 0.5 percent to about 2.0 percent of the plasticizer.
Preferably, when the evaporative solvent comprises isooctane and hexamethyldisiloxane, the ratio of isooctane to hexamethyldisiloxane is about 3:5. When the evaporatiye solvent comprises isooctane, isododecane, and hexamethyldisiloxane, the ratio of isooctane, isododecane, and hexamethyldisiloxane is preferably about 19:11:50.
In a particularly preferred embodiment, the composition comprises:
(1) about 19% cycloalkyl methacrylate copolymer;
(2) about 1% of acetyl tributyl citrate;
(3) about 30% of isooctane; and
(4) about 50% of hexamethyldisiloxane.
In an alternative embodiment, the composition comprises:
(1) about 19% cycloalkyl methacrylate copolymer;
(2) about 1% of acetyl tributyl citrate;
(3) about 19% of isooctane;
(4) about 11% of isododecane; and
(5) about 50% of hexamethyldisiloxane.
›DESCRIPTION
An improved skin-protecting film-forming composition uses the polymer cycloalkyl methacrylate copolymer. This creates a unique protectant film when the polymer is dispersed in a solvent system that evaporates rapidly.
In general, a composition of the present invention is a composition that dries to produce a protectant film for skin when applied to the skin of a user. The composition comprises:
(1) cycloalkyl methacrylate copolymer;
(2) an evaporative solvent comprising at least one solvent for the cycloalkyl methacrylate copolymer that can evaporate so that the copolymer is deposited on the skin; and
(3) a plasticizer to provide flexibility to the film deposited on the skin.
A suitable source of a cycloalkyl methacrylate copolymer that is useful in compositions according to the present invention is Phoenix Chemical, Inc. of Somerville, N.J. A particularly suitable cycloalkyl methacrylate copolymer is a bicycloalkyl methacrylate copolymer marketed by Phoenix Chemical as Giovarez AC-5099M.
Typically, the solvent system comprises hexamethyldisiloxane and at least one saturated branched-chain hydrocarbon selected from the group consisting of isooctane, isodecane, and isododecane. Preferably, the saturated branched-chain hydrocarbon is a mixture of isooctane and isododecane. Alternatively, the saturated branched-chain hydrocarbon can be isooctane. Other saturated branched-chain hydrocarbons can be used.
Typically, the plasticizer is selected from the group consisting of acetyl tributyl citrate, acetyl triethyl citrate, tributyl citrate, triethyl citrate, acetyl tripropyl citrate, tripropyl citrate, dibutyl sebacate, acetyl dibutyl sebacate, dipropyl sebacate, acetyl dipropyl sebacate, diethyl sebacate, and acetyl diethyl sebacate. Preferably, the plasticizer is acetyl tributyl citrate. Other plasticizers can be used, including homologues and derivatives of these esters.
Preferably, the composition comprises from about 5% to about 25% of the cycloalkyl methacrylate copolymer, from about 73% to about 94.5% of the evaporative solvent, and from about 0.5% to about 2.0% of the plasticizer.
Where the evaporative solvent comprises isooctane and hexamethyldisiloxane, the ratio of isooctane to hexamethyldisiloxane is preferably about 3:5. When the evaporative solvent comprises isooctane, isododecane, and hexamethyldisiloxane, the ratio of isooctane, isododecane, and hexamethyldisiloxane is preferably about 19:11:50.
In a particularly preferred embodiment, the composition comprises:
(1) about 19% cycloalkyl methacrylate copolymer;
(2) about 1% of acetyl tributyl citrate;
(3) about 30% of isooctane; and
(4) about 50% of hexamethyldisiloxane.
In an alternative embodiment, the composition comprises:
(1) about 19% cycloalkyl methacrylate copolymer;
(2) about 1% of acetyl tributyl citrate;
(3) about 19% of isooctane;
(4) about 11% of isododecane; and
(5) about 50% of hexamethyldisiloxane.
The composition is made by adding the solvents (isooctane and/or isododecane and hexamethyldisiloxane) to the polymer and plasticizer and mixing with vigorous agitation.
The polymer is applied to the skin and forms a protective film that can be used, for example, to cover ostomy apertures, wounds, and other openings in the skin.
›ADVANTAGES OF THE INVENTION
The present invention provides a protectant film that leaves a clear film on the skin. The skin is flexible on the skin so that it will not crack or flake. The film does not interfere with adhesion of ostomy appliances, wound care dressing, tape, or attachable breast forms. The film protects skin against urine, feces, enzymatic drainage, wound drainage or adhesive trauma. The application of the film leaves a shiny appearance so that one can see that the film has been applied.
The composition of the present invention is non-stinging. The solvent of the composition evaporates rapidly, leaving a dry film. These properties enhance the performance of the composition.
Although the present invention has been described in considerable detail, with reference to certain preferred versions thereof, other versions and embodiments are possible. Therefore, the scope of the invention is determined by the following claims.
Claims as granted
15 claimsLog in to read the claims of this application.
Log in to unlockClassifications
4 codes- A61L26/00
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlock